Hi-Sci Solutions Limited leverages the regenerative, immunomodulatory, and anti-inflammatory power of MSC-derived exosomes to develop breakthrough treatments for rare and severe inflammatory diseases with unmet medical needs.

The Science Behind Exosomes

Exosomes are nanoscale extracellular vesicles (30–150 nm) naturally secreted by cells to facilitate intercellular communication. These vesicles transport bioactive molecules, including proteins, lipids, and nucleic acids, orchestrating fundamental cellular processes such as tissue regeneration, immune regulation, and inflammation control. Their ability to cross physiological barriers, exhibit high biocompatibility, and deliver therapeutic payloads with minimal immune activation makes them an ideal vehicle for next-generation drug delivery.

Revolutionising Medicine with Engineered Exosome-Based Therapies

At Hi-Sci Solutions Limited, we are pioneering exosome-based therapeutics, redefining precision medicine through advanced bioengineering and targeted drug delivery systems. Our research leverages the intrinsic properties of mesenchymal stem cell (MSC)-derived exosomes, harnessing their regenerative, immunomodulatory, and anti-inflammatory capabilities to develop transformative therapies for rare and treatment-resistant inflammatory diseases.

Our Technology: Engineering Exosomes for Targeted Therapeutics

At Hi-Sci Solutions Limited, we have developed a proprietary platform technology to bioengineer exosomes, optimizing them as highly efficient nanocarriers for precision medicine. Our approach enables:

High-capacity drug loading – Incorporating large therapeutic payloads, including biologics, small molecules, and genetic material, to enhance clinical efficacy.

Targeted organ delivery – Engineering exosomes with surface modifications to maximize biodistribution and therapeutic impact at disease sites.

Scalable manufacturing – Developing robust, reproducible exosome production processes to ensure clinical-grade purity, stability, and potency.